Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -170.19% is 206% below its 5-year average of -55.61%, near the low end of its 5-year range (-170.19%–-22.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 62.30% below its 12-month average of -104.86%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -170.19%.
RETURN ON INVESTED CAPITAL (ROIC)
-170.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-104.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-74.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-55.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-65.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-54.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-46.09%
CURRENT VS TTM AVG
-62.30%
CURRENT VS 3Y AVG
-129.87%
CURRENT VS 5Y AVG
-206.04%
CURRENT VS 10Y AVG
-159.50%
CURRENT VS 15Y AVG
-209.91%
CURRENT VS 20Y AVG
-269.24%
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
-394.24%
vs the sector median at left
EyePoint Pharmaceuticals, Inc.
Market Cap
$267.03M
Return on Invested Capital (ROIC)
-170.19%
TTM Avg
-104.86%
3Y Avg
-74.04%
5Y Avg
-55.61%
Market Cap
$265.50M
Return on Invested Capital (ROIC)
-43.56%
TTM Avg
-66.27%
3Y Avg
-114.94%
5Y Avg
-104.61%
Market Cap
$265.41M
Return on Invested Capital (ROIC)
-15.00%
TTM Avg
-11.69%
3Y Avg
-3.29%
5Y Avg
-2.92%
Market Cap
$264.73M
Return on Invested Capital (ROIC)
-42.92%
TTM Avg
-30.10%
3Y Avg
-80.25%
5Y Avg
-64.52%
Market Cap
$269.92M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.65M
Return on Invested Capital (ROIC)
-39.76%
TTM Avg
-63.41%
3Y Avg
-63.96%
5Y Avg
-51.83%
Market Cap
$271.90M
Return on Invested Capital (ROIC)
-48.92%
TTM Avg
-66.11%
3Y Avg
-56.53%
5Y Avg
-47.58%
Market Cap
$261.24M
Return on Invested Capital (ROIC)
-28.96%
TTM Avg
-103.16%
3Y Avg
-110.30%
5Y Avg
-171.09%
Market Cap
$273.33M
Return on Invested Capital (ROIC)
-58.72%
TTM Avg
-52.25%
3Y Avg
-49.23%
5Y Avg
-41.07%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | $267.03M | -170.19% | -104.86% | -74.04% | -55.61% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $265.50M | -43.56% | -66.27% | -114.94% | -104.61% |
| OraSure Technologies, Inc. (OSUR)vs › | $265.41M | -15.00% | -11.69% | -3.29% | -2.92% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.73M | -42.92% | -30.10% | -80.25% | -64.52% |
| Scribe Therapeutics Inc. (SCTX)vs › | $269.92M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $262.65M | -39.76% | -63.41% | -63.96% | -51.83% |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $271.90M | -48.92% | -66.11% | -56.53% | -47.58% |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | -28.96% | -103.16% | -110.30% | -171.09% |
| Fate Therapeutics, Inc. (FATE)vs › | $273.33M | -58.72% | -52.25% | -49.23% | -41.07% |
| AC Immune S.A. (ACIU)vs › | $259.52M | -89.43% | -77.88% | -57.02% | -48.01% |
ROIC
-170.2%
ROE
-184.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -170.19% |
| 2026-03-31 | -111.46% |
| 2025-12-31 | -74.45% |
| 2025-09-30 | -97.66% |
| 2025-06-30 | -70.55% |
| 2025-03-31 | -50.29% |
| 2024-12-31 | -39.48% |
| 2024-09-30 | -46.39% |
| 2024-06-30 | -37.62% |
| 2024-03-31 | -32.43% |
| 2023-12-31 | -25.67% |
| 2023-09-30 | -106.55% |
| 2023-06-30 | -99.73% |
| 2023-03-31 | -77.58% |
| 2022-12-31 | -63.75% |
| 2022-09-30 | -37.59% |
| 2022-06-30 | -33.66% |
| 2022-03-31 | -28.08% |
| 2021-12-31 | -23.06% |
| 2021-09-30 | -33.69% |
| 2021-06-30 | -22.52% |
| 2021-03-31 | -21.18% |
| 2020-12-31 | -48.54% |
| 2020-09-30 | -52.51% |
| 2020-06-30 | -75.94% |
| 2020-03-31 | -63.80% |
| 2019-12-31 | -77.88% |
| 2019-09-30 | -37.02% |
| 2019-06-30 | -30.92% |
| 2019-03-31 | -42.60% |
| 2018-12-31 | -25.69% |
| 2018-09-30 | -50.91% |
| 2018-06-30 | -52.54% |
| 2018-03-31 | -78.18% |
| 2017-12-31 | -232.33% |
| 2017-09-30 | -192.26% |
| 2017-06-30 | -138.76% |
| 2017-03-31 | -150.39% |
| 2016-12-31 | -127.08% |
| 2016-09-30 | -119.34% |
| 2016-06-30 | -82.09% |
| 2016-03-31 | -63.73% |
| 2015-12-31 | -102.03% |
| 2015-09-30 | -79.09% |
| 2015-06-30 | 21.80% |
| 2015-03-31 | 22.42% |
| 2014-12-31 | 27.25% |
| 2014-09-30 | 26.29% |
| 2014-06-30 | -65.66% |
| 2014-03-31 | -56.68% |
| 2013-12-31 | -75.27% |
| 2013-09-30 | -66.20% |
| 2013-06-30 | -92.93% |
| 2013-03-31 | -63.04% |
| 2012-12-31 | -54.20% |
| 2012-09-30 | -60.52% |
| 2012-06-30 | -68.72% |
| 2012-03-31 | -49.24% |
| 2011-12-31 | -46.52% |
| 2011-09-30 | -23.24% |
| 2011-06-30 | -23.77% |
| 2011-03-31 | 5.45% |
| 2010-09-30 | 14.79% |
| 2010-06-30 | 22.62% |
| 2010-03-31 | 26.82% |
| 2009-12-31 | 31.77% |
| 2009-09-30 | 28.58% |
| 2009-06-30 | 19.42% |
| 2009-03-31 | -37.96% |
| 2008-12-31 | -59.15% |
| 2008-09-30 | -65.65% |
| 2008-06-30 | -64.66% |
| 2008-03-31 | -31.58% |
| 2007-12-31 | -25.81% |
| 2007-09-30 | -24.53% |
| 2007-06-30 | -28.46% |
| 2005-06-30 | -87.53% |
| 2004-06-30 | -55.14% |
| 2003-06-30 | -149.87% |
